๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Limitations of controlled augmentation trials in schizophrenia

โœ Scribed by Robert G. Stern; James Schmeidler; Michael Davidson

Book ID
118510891
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
541 KB
Volume
42
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Placebo-controlled trials in schizophren
Placebo-controlled trials in schizophrenia
โœ J.G. Storosum; A. Elferink; B.J. van Zwieten-Boot ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 176 KB
Fluvoxamine augmentation in risperidone-
Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial
โœ Hitoshi Takashi; Takio Sugita; Hisashi Higuchi; Tetsuo Shimizu ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 51 KB ๐Ÿ‘ 1 views

We investigated the efficacy and safety of augmenting risperidone with fluvoxamine for the treatment of residual positive and negative symptoms in patients with chronic schizophrenia who had shown an incomplete response to risperidone. A total of 30 patients completed the open trial over a 12-week p